<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d49b8-2c06-7812-87c8-3afdc9cbe7b0,g:b23965f9-2118-4c63-a9bf-373774c39af3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="abos-20260331.xsd#CondensedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-7279-ad06-006f44ed8917" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019d49b8-2ce2-7b46-aaa3-ae7217b0ccdb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-7279-ad06-006f44ed8917" xlink:to="loc_us-gaap_PreferredStockValue_019d49b8-2ce2-7b46-aaa3-ae7217b0ccdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d49b8-2ce2-7402-af99-3345e00ecc87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-7279-ad06-006f44ed8917" xlink:to="loc_us-gaap_CommonStockValue_019d49b8-2ce2-7402-af99-3345e00ecc87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019d49b8-2ce2-7994-9203-d31feafafbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-7279-ad06-006f44ed8917" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019d49b8-2ce2-7994-9203-d31feafafbf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d49b8-2ce2-7888-95c8-788592789494" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-7279-ad06-006f44ed8917" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d49b8-2ce2-7888-95c8-788592789494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019d49b8-2ce2-755c-876d-f639f3cd2482" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-7279-ad06-006f44ed8917" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019d49b8-2ce2-755c-876d-f639f3cd2482" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d49b8-2ce2-7f32-b197-81c9c48435b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d49b8-2ce2-787a-9aa7-4af675aa48c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d49b8-2ce2-7f32-b197-81c9c48435b9" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d49b8-2ce2-787a-9aa7-4af675aa48c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019d49b8-2ce2-74f5-9ff4-7b1fd5b576dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d49b8-2ce2-7f32-b197-81c9c48435b9" xlink:to="loc_us-gaap_LongTermDebt_019d49b8-2ce2-74f5-9ff4-7b1fd5b576dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d49b8-2ce2-73d0-92fc-3f99d23a2dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d49b8-2ce2-79b1-abcd-287f0c1e46c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d49b8-2ce2-73d0-92fc-3f99d23a2dd4" xlink:to="loc_us-gaap_Liabilities_019d49b8-2ce2-79b1-abcd-287f0c1e46c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019d49b8-2ce2-7310-ad38-316b6448f164" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d49b8-2ce2-73d0-92fc-3f99d23a2dd4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019d49b8-2ce2-7310-ad38-316b6448f164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-749a-af1e-7fbac9d70e15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d49b8-2ce2-73d0-92fc-3f99d23a2dd4" xlink:to="loc_us-gaap_StockholdersEquity_019d49b8-2ce2-749a-af1e-7fbac9d70e15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d49b8-2ce2-7fef-9542-af8900a5701f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d49b8-2ce2-75fa-9fd7-dd19dd612b16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d49b8-2ce2-7fef-9542-af8900a5701f" xlink:to="loc_us-gaap_AssetsCurrent_019d49b8-2ce2-75fa-9fd7-dd19dd612b16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019d49b8-2ce2-7960-852a-a06bd003884b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d49b8-2ce2-7fef-9542-af8900a5701f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019d49b8-2ce2-7960-852a-a06bd003884b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce2-7da2-a5dd-8fb1ab38bc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d49b8-2ce2-7fef-9542-af8900a5701f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce2-7da2-a5dd-8fb1ab38bc6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d49b8-2ce2-7559-a0e0-5ec057de7a96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_019d49b8-2ce2-70b1-957d-fd85b068022d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d49b8-2ce2-7559-a0e0-5ec057de7a96" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_019d49b8-2ce2-70b1-957d-fd85b068022d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d49b8-2ce2-737e-b025-f926d775fcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d49b8-2ce2-7559-a0e0-5ec057de7a96" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d49b8-2ce2-737e-b025-f926d775fcb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce2-7629-a45b-e0bdfac61f82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d49b8-2ce2-7559-a0e0-5ec057de7a96" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce2-7629-a45b-e0bdfac61f82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d49b8-2ce2-7803-8125-d83d114a4bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_AccruedClinicalTrialExpensesCurrent_019d49b8-2ce2-7c61-ac53-8ee9dada5fb7" xlink:href="abos-20260331.xsd#abos_AccruedClinicalTrialExpensesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d49b8-2ce2-7803-8125-d83d114a4bfd" xlink:to="loc_abos_AccruedClinicalTrialExpensesCurrent_019d49b8-2ce2-7c61-ac53-8ee9dada5fb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019d49b8-2ce2-77a7-a517-dfe927130b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d49b8-2ce2-7803-8125-d83d114a4bfd" xlink:to="loc_us-gaap_AccountsPayableCurrent_019d49b8-2ce2-77a7-a517-dfe927130b5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d49b8-2ce2-7de5-b400-42ec7ee18c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d49b8-2ce2-7803-8125-d83d114a4bfd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d49b8-2ce2-7de5-b400-42ec7ee18c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_019d49b8-2ce2-7ccc-9c0b-5733276c61dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d49b8-2ce2-7803-8125-d83d114a4bfd" xlink:to="loc_us-gaap_ShortTermBorrowings_019d49b8-2ce2-7ccc-9c0b-5733276c61dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="abos-20260331.xsd#CondensedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d49b8-2ce2-7491-b2b3-b729624cf1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d49b8-2ce2-7440-927b-bc1d01ff6136" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d49b8-2ce2-7491-b2b3-b729624cf1a9" xlink:to="loc_us-gaap_OperatingExpenses_019d49b8-2ce2-7440-927b-bc1d01ff6136" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2ce2-76ca-acf0-2a55f7a13953" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019d49b8-2ce2-7410-8bf3-3952b5da68e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2ce2-76ca-acf0-2a55f7a13953" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019d49b8-2ce2-7410-8bf3-3952b5da68e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019d49b8-2ce2-7a5a-a22f-c322dcb0b22d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2ce2-76ca-acf0-2a55f7a13953" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019d49b8-2ce2-7a5a-a22f-c322dcb0b22d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d49b8-2ce2-7449-b005-35ced7467363" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2ce2-76ca-acf0-2a55f7a13953" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d49b8-2ce2-7449-b005-35ced7467363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019d49b8-2ce2-728c-bf46-5083f680ac67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2ce2-76ca-acf0-2a55f7a13953" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019d49b8-2ce2-728c-bf46-5083f680ac67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d49b8-2ce2-79c6-8fcd-032b169c1a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d49b8-2ce2-725e-ae3d-9f935bfffd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d49b8-2ce2-79c6-8fcd-032b169c1a9e" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d49b8-2ce2-725e-ae3d-9f935bfffd8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2ce2-763a-b8ba-9e2e8894a1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d49b8-2ce2-79c6-8fcd-032b169c1a9e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2ce2-763a-b8ba-9e2e8894a1fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d49b8-2ce2-7fd8-9f41-b98daec3ecb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d49b8-2ce2-7299-ba0d-eb8b90957262" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d49b8-2ce2-7fd8-9f41-b98daec3ecb1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d49b8-2ce2-7299-ba0d-eb8b90957262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d49b8-2ce2-7efd-94f7-9c09d23d5726" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d49b8-2ce2-7fd8-9f41-b98daec3ecb1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d49b8-2ce2-7efd-94f7-9c09d23d5726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d49b8-2ce2-7f95-85da-20da4e9c3732" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019d49b8-2ce2-7110-aefd-e3d00817e375" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d49b8-2ce2-7f95-85da-20da4e9c3732" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019d49b8-2ce2-7110-aefd-e3d00817e375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d49b8-2ce2-793d-bb41-96e85feec5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d49b8-2ce2-7f95-85da-20da4e9c3732" xlink:to="loc_us-gaap_NetIncomeLoss_019d49b8-2ce2-793d-bb41-96e85feec5c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="abos-20260331.xsd#CondensedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d49b8-2ce2-7398-ba7b-fc5f1eb223a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_019d49b8-2ce2-7d1e-bb95-144d6aa2fab1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d49b8-2ce2-7398-ba7b-fc5f1eb223a7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_019d49b8-2ce2-7d1e-bb95-144d6aa2fab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_019d49b8-2ce2-7c7c-879b-5815efb4185d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d49b8-2ce2-7398-ba7b-fc5f1eb223a7" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_019d49b8-2ce2-7c7c-879b-5815efb4185d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_019d49b8-2ce2-70c1-8029-a9289323a118" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d49b8-2ce2-7398-ba7b-fc5f1eb223a7" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_019d49b8-2ce2-70c1-8029-a9289323a118" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d49b8-2ce2-7e0d-b907-89d4eab43c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019d49b8-2ce2-788d-bb69-24d2ff5bf2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d49b8-2ce2-7e0d-b907-89d4eab43c5b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019d49b8-2ce2-788d-bb69-24d2ff5bf2b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019d49b8-2ce2-78e1-bee7-30704738faf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d49b8-2ce2-7e0d-b907-89d4eab43c5b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019d49b8-2ce2-78e1-bee7-30704738faf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d49b8-2ce2-73e0-8d02-3f3c2fcbc952" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d49b8-2ce2-7e0d-b907-89d4eab43c5b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d49b8-2ce2-73e0-8d02-3f3c2fcbc952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019d49b8-2ce2-7b3f-9447-ac229cd318b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d49b8-2ce2-7d34-bcc8-a937f882a305" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019d49b8-2ce2-7b3f-9447-ac229cd318b7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d49b8-2ce2-7d34-bcc8-a937f882a305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7b37-8738-3b372d2ad6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019d49b8-2ce2-7b3f-9447-ac229cd318b7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7b37-8738-3b372d2ad6bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d49b8-2ce2-7c95-a50b-84c15f3434f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_019d49b8-2ce2-7b3f-9447-ac229cd318b7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d49b8-2ce2-7c95-a50b-84c15f3434f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d49b8-2ce2-7447-bcf8-474edcf9601d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_NetIncomeLoss_019d49b8-2ce2-7447-bcf8-474edcf9601d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019d49b8-2ce2-73ef-9493-c262b9f8c9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_Depreciation_019d49b8-2ce2-73ef-9493-c262b9f8c9fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d49b8-2ce2-7903-8fe1-6b92d9fc82c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_ShareBasedCompensation_019d49b8-2ce2-7903-8fe1-6b92d9fc82c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d49b8-2ce2-7fb8-85ae-f38df3d8c4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d49b8-2ce2-7fb8-85ae-f38df3d8c4bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019d49b8-2ce2-76ec-94ce-014ac33d770f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_019d49b8-2ce2-76ec-94ce-014ac33d770f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019d49b8-2ce2-700b-aac9-a57ae9af579c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019d49b8-2ce2-700b-aac9-a57ae9af579c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_019d49b8-2ce2-7cdd-8d6b-bf053d2e2512" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_019d49b8-2ce2-7cdd-8d6b-bf053d2e2512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_OtherNoncashExpenseInterest_019d49b8-2ce2-7873-918b-f40fa0cb2abb" xlink:href="abos-20260331.xsd#abos_OtherNoncashExpenseInterest"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_abos_OtherNoncashExpenseInterest_019d49b8-2ce2-7873-918b-f40fa0cb2abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d49b8-2ce2-7c99-8626-868d8befbfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d49b8-2ce2-7c99-8626-868d8befbfdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019d49b8-2ce2-76f2-8daa-c51992a62e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019d49b8-2ce2-76f2-8daa-c51992a62e6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d49b8-2ce2-70ec-888d-453ceb1ed3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d49b8-2ce2-70ec-888d-453ceb1ed3c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_IncreaseDecreaseInAccruedClinicalTrialExpenses_019d49b8-2ce2-705d-b960-88613c7a1c0a" xlink:href="abos-20260331.xsd#abos_IncreaseDecreaseInAccruedClinicalTrialExpenses"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_abos_IncreaseDecreaseInAccruedClinicalTrialExpenses_019d49b8-2ce2-705d-b960-88613c7a1c0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d49b8-2ce2-753e-8368-bb7ac6386f14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d49b8-2ce2-7ab4-aec4-f3a9c7969c2e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d49b8-2ce2-753e-8368-bb7ac6386f14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d49b8-2ce2-73ab-8eb0-6243d9ac87a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_019d49b8-2ce2-7c78-b043-4cc5529455be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d49b8-2ce2-73ab-8eb0-6243d9ac87a5" xlink:to="loc_us-gaap_RestrictedCash_019d49b8-2ce2-7c78-b043-4cc5529455be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d49b8-2ce2-7497-bc69-8ee792c954bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d49b8-2ce2-73ab-8eb0-6243d9ac87a5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d49b8-2ce2-7497-bc69-8ee792c954bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019d49b8-2ce2-7ce3-a7cb-d679bd44e8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019d49b8-2ce2-7e35-92d4-650fc55d6cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019d49b8-2ce2-7ce3-a7cb-d679bd44e8a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019d49b8-2ce2-7e35-92d4-650fc55d6cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_019d49b8-2ce2-7389-9a81-276a62281e96" xlink:href="abos-20260331.xsd#abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019d49b8-2ce2-7ce3-a7cb-d679bd44e8a8" xlink:to="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_019d49b8-2ce2-7389-9a81-276a62281e96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_019d49b8-2ce2-7649-9231-078c0a13aa4f" xlink:href="abos-20260331.xsd#abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_019d49b8-2ce2-7ce3-a7cb-d679bd44e8a8" xlink:to="loc_abos_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_019d49b8-2ce2-7649-9231-078c0a13aa4f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/MARKETABLESECURITIESScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019d49b8-2ce2-7492-938d-c74a8d09b257" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019d49b8-2ce2-7a6f-94b7-faf44de92a98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019d49b8-2ce2-7492-938d-c74a8d09b257" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019d49b8-2ce2-7a6f-94b7-faf44de92a98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019d49b8-2ce2-7298-bc66-98e9519e5e83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019d49b8-2ce2-7492-938d-c74a8d09b257" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019d49b8-2ce2-7298-bc66-98e9519e5e83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019d49b8-2ce2-7098-a348-29e1f7b1cbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019d49b8-2ce2-7c87-8706-83d8a55e169c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019d49b8-2ce2-7098-a348-29e1f7b1cbd1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019d49b8-2ce2-7c87-8706-83d8a55e169c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019d49b8-2ce2-7bb2-8f9d-a174ff30f18b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019d49b8-2ce2-7098-a348-29e1f7b1cbd1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019d49b8-2ce2-7bb2-8f9d-a174ff30f18b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019d49b8-2ce2-7c6a-b1f5-3456fe7a2a88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019d49b8-2ce2-7640-afab-ed848604f017" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019d49b8-2ce2-7c6a-b1f5-3456fe7a2a88" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019d49b8-2ce2-7640-afab-ed848604f017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_019d49b8-2ce2-7848-87b8-e7564eac5915" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019d49b8-2ce2-7c6a-b1f5-3456fe7a2a88" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_019d49b8-2ce2-7848-87b8-e7564eac5915" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019d49b8-2ce2-7be7-ba53-7f0748a61415" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019d49b8-2ce2-7a08-a7b9-ac5eb24d32a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019d49b8-2ce2-7be7-ba53-7f0748a61415" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019d49b8-2ce2-7a08-a7b9-ac5eb24d32a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreements_019d49b8-2ce3-7f57-9bc1-306aaaa246d3" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentServiceAgreements"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019d49b8-2ce3-7567-9f70-9034db3dadb8" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentServiceAgreementsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_abos_ResearchAndDevelopmentServiceAgreements_019d49b8-2ce3-7f57-9bc1-306aaaa246d3" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019d49b8-2ce3-7567-9f70-9034db3dadb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019d49b8-2ce3-7e5e-9d6a-48da39ff2907" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentServiceAgreementsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_abos_ResearchAndDevelopmentServiceAgreements_019d49b8-2ce3-7f57-9bc1-306aaaa246d3" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019d49b8-2ce3-7e5e-9d6a-48da39ff2907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce3-742b-a11f-1030979a3da9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d49b8-2ce3-7d94-b30d-91c2ca4ab75b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce3-742b-a11f-1030979a3da9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d49b8-2ce3-7d94-b30d-91c2ca4ab75b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d49b8-2ce3-7d7f-9ade-9d6c71778999" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce3-742b-a11f-1030979a3da9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d49b8-2ce3-7d7f-9ade-9d6c71778999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019d49b8-2ce3-7bde-8f43-644a2b41a1a9" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentServiceAgreementsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce3-742b-a11f-1030979a3da9" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsNoncurrent_019d49b8-2ce3-7bde-8f43-644a2b41a1a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d49b8-2ce3-7117-b554-cc0d6ec87221" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce3-742b-a11f-1030979a3da9" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d49b8-2ce3-7117-b554-cc0d6ec87221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7613-9f73-ecea3cff1a14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019d49b8-2ce3-7bf2-8a87-d90ad51cad1e" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentServiceAgreementsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7613-9f73-ecea3cff1a14" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreementsCurrent_019d49b8-2ce3-7bf2-8a87-d90ad51cad1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_019d49b8-2ce3-700e-a7a6-e72456abc2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7613-9f73-ecea3cff1a14" xlink:to="loc_us-gaap_OtherReceivables_019d49b8-2ce3-700e-a7a6-e72456abc2bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019d49b8-2ce3-74ed-b43c-2a4399aff7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7613-9f73-ecea3cff1a14" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019d49b8-2ce3-74ed-b43c-2a4399aff7c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019d49b8-2ce3-7a42-80b1-e11f05f50408" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7613-9f73-ecea3cff1a14" xlink:to="loc_us-gaap_PrepaidInsurance_019d49b8-2ce3-7a42-80b1-e11f05f50408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DuesAndSubscriptions_019d49b8-2ce3-762c-b1ed-633b5210b8ef" xlink:href="abos-20260331.xsd#abos_DuesAndSubscriptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7613-9f73-ecea3cff1a14" xlink:to="loc_abos_DuesAndSubscriptions_019d49b8-2ce3-762c-b1ed-633b5210b8ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_019d49b8-2ce3-763b-8342-cbedf9e313de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019d49b8-2ce3-7857-9add-f0a7c7b3869a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous_019d49b8-2ce3-763b-8342-cbedf9e313de" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_019d49b8-2ce3-7857-9add-f0a7c7b3869a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d49b8-2ce3-7902-8a47-60025d603295" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous_019d49b8-2ce3-763b-8342-cbedf9e313de" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d49b8-2ce3-7902-8a47-60025d603295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentServiceAgreements_019d49b8-2ce3-7470-b701-e353d295475b" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentServiceAgreements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:to="loc_abos_ResearchAndDevelopmentServiceAgreements_019d49b8-2ce3-7470-b701-e353d295475b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_019d49b8-2ce3-7d9c-a260-bb9250e3e82e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_019d49b8-2ce3-7d9c-a260-bb9250e3e82e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_019d49b8-2ce3-76f1-b313-d3ad7f374f52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:to="loc_us-gaap_OtherReceivables_019d49b8-2ce3-76f1-b313-d3ad7f374f52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d49b8-2ce3-727c-bbf1-5f69f06ec091" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d49b8-2ce3-727c-bbf1-5f69f06ec091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019d49b8-2ce3-7fa4-a95f-2e362212bb20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:to="loc_us-gaap_PrepaidInsurance_019d49b8-2ce3-7fa4-a95f-2e362212bb20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_DuesAndSubscriptions_019d49b8-2ce3-7908-800d-06c2129448c9" xlink:href="abos-20260331.xsd#abos_DuesAndSubscriptions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:to="loc_abos_DuesAndSubscriptions_019d49b8-2ce3-7908-800d-06c2129448c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d49b8-2ce3-7651-9e7e-05834feaa7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-75de-81d2-0221be796151" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d49b8-2ce3-7651-9e7e-05834feaa7d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1" xlink:type="simple" xlink:href="abos-20260331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofPrepaidExpensesandOtherCurrentAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-71e7-970a-a2768f6ee84a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce3-72bb-810d-83855d967e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-71e7-970a-a2768f6ee84a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d49b8-2ce3-72bb-810d-83855d967e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7485-b827-410d9fc44a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_019d49b8-2ce3-71e7-970a-a2768f6ee84a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d49b8-2ce3-7485-b827-410d9fc44a2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019d49b8-2ce3-7851-99ad-a3a9d25e98fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentLiability_019d49b8-2ce3-7bbc-86a3-48ed529eaf31" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019d49b8-2ce3-7851-99ad-a3a9d25e98fd" xlink:to="loc_abos_ResearchAndDevelopmentLiability_019d49b8-2ce3-7bbc-86a3-48ed529eaf31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_019d49b8-2ce3-7b38-8b3d-95b2f814caa9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019d49b8-2ce3-7851-99ad-a3a9d25e98fd" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_019d49b8-2ce3-7b38-8b3d-95b2f814caa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019d49b8-2ce3-7334-9cb2-c0de5934dece" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019d49b8-2ce3-7851-99ad-a3a9d25e98fd" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019d49b8-2ce3-7334-9cb2-c0de5934dece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019d49b8-2ce3-7596-bad0-d633f53fb3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019d49b8-2ce3-7851-99ad-a3a9d25e98fd" xlink:to="loc_us-gaap_OperatingLeaseLiability_019d49b8-2ce3-7596-bad0-d633f53fb3f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilities_019d49b8-2ce3-7430-814b-ee70ec82534e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSundryLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_019d49b8-2ce3-7851-99ad-a3a9d25e98fd" xlink:to="loc_us-gaap_OtherSundryLiabilities_019d49b8-2ce3-7430-814b-ee70ec82534e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#DEBTScheduleofOutstandingDebtDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019d49b8-2da2-7ec3-8302-326bfcc8da38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_019d49b8-2da2-7c23-86b8-a39c1a0bf7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019d49b8-2da2-7ec3-8302-326bfcc8da38" xlink:to="loc_us-gaap_ShortTermBorrowings_019d49b8-2da2-7c23-86b8-a39c1a0bf7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019d49b8-2da2-763f-8919-0d8b385f7d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019d49b8-2da2-7ec3-8302-326bfcc8da38" xlink:to="loc_us-gaap_LongTermDebt_019d49b8-2da2-763f-8919-0d8b385f7d2a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails_1" xlink:type="simple" xlink:href="abos-20260331.xsd#DEBTScheduleofOutstandingDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofOutstandingDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019d49b8-2da2-7f5b-852c-8c6f109b4734" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019d49b8-2da2-7bd9-a12d-100e34e36627" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019d49b8-2da2-7f5b-852c-8c6f109b4734" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_019d49b8-2da2-7bd9-a12d-100e34e36627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019d49b8-2da2-7c8e-9ec7-062ae33a2c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019d49b8-2da2-7f5b-852c-8c6f109b4734" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_019d49b8-2da2-7c8e-9ec7-062ae33a2c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019d49b8-2da2-77d4-bcf8-247b2f4497a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_019d49b8-2da2-7f5b-852c-8c6f109b4734" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019d49b8-2da2-77d4-bcf8-247b2f4497a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofInterestExpenseDebtDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#DEBTScheduleofInterestExpenseDebtDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofInterestExpenseDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_019d49b8-2da2-7c35-907d-f37aa75eae77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_019d49b8-2da2-7a18-b778-20f2aa4c6f97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_019d49b8-2da2-7c35-907d-f37aa75eae77" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_019d49b8-2da2-7a18-b778-20f2aa4c6f97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019d49b8-2da2-7089-a23b-9c77af3fcef5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_019d49b8-2da2-7c35-907d-f37aa75eae77" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019d49b8-2da2-7089-a23b-9c77af3fcef5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/DEBTScheduleofAggregatePrincipalPaymentsDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#DEBTScheduleofAggregatePrincipalPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/DEBTScheduleofAggregatePrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019d49b8-2da2-7a1f-a846-41be21ba4a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019d49b8-2da2-7e0f-9795-8a991ada464f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_019d49b8-2da2-7a1f-a846-41be21ba4a9e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019d49b8-2da2-7e0f-9795-8a991ada464f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019d49b8-2da2-70ce-8448-5c244ca06b45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_019d49b8-2da2-7a1f-a846-41be21ba4a9e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019d49b8-2da2-70ce-8448-5c244ca06b45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.acumenpharm.com/role/SEGMENTREPORTINGScheduleofSegmentReportingInformationDetails" xlink:type="simple" xlink:href="abos-20260331.xsd#SEGMENTREPORTINGScheduleofSegmentReportingInformationDetails"/>
  <link:calculationLink xlink:role="http://www.acumenpharm.com/role/SEGMENTREPORTINGScheduleofSegmentReportingInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d49b8-2da3-7cb9-8449-b54e2c13457a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019d49b8-2da3-76fa-9927-8c07e96920b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d49b8-2da3-7cb9-8449-b54e2c13457a" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019d49b8-2da3-76fa-9927-8c07e96920b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2da3-7294-a6e5-dadaf90db3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d49b8-2da3-7cb9-8449-b54e2c13457a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019d49b8-2da3-7294-a6e5-dadaf90db3e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentExternalCosts_019d49b8-2da3-7742-ae76-b55b3471562d" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentExternalCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d49b8-2da3-7cb9-8449-b54e2c13457a" xlink:to="loc_abos_ResearchAndDevelopmentExternalCosts_019d49b8-2da3-7742-ae76-b55b3471562d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d49b8-2da3-7bf8-885b-5a0b0e17ffad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d49b8-2da3-7cb9-8449-b54e2c13457a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d49b8-2da3-7bf8-885b-5a0b0e17ffad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_abos_ResearchAndDevelopmentInternallyManagedCosts_019d49b8-2da3-7235-9d8f-3a4ef9984dd3" xlink:href="abos-20260331.xsd#abos_ResearchAndDevelopmentInternallyManagedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d49b8-2da3-7cb9-8449-b54e2c13457a" xlink:to="loc_abos_ResearchAndDevelopmentInternallyManagedCosts_019d49b8-2da3-7235-9d8f-3a4ef9984dd3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
